+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chemiluminescence Immunoassay Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 210 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5455981
Chemiluminescent immunoassay (CLIA) is a biochemical technique used in immunology that is a variation of the standard enzyme immunoassay (EIA). They can also be used as diagnostic tools in medicine, as well as in a variety of other industries such as for food safety and pharmaceutical analysis, environmental monitoring, and many more.



There are two type of chemiluminescence immunoassay methods:

  • Indirect CLIA with enzyme markers- An enzyme, typically horse radish peroxidase (HRP) or alkaline phosphatase (AP), is conjugated to a secondary antibody in this common CLIA method.
  • Direct CLIA with luminophore markers- To generate a signal, acridinium esters are commonly used as luminophores and are conjugated directly to the primary monoclonal antibody.

Market Dynamics


Market players are focused on supplying products to hospitals and government organizations, this could contribute to the growth of the global chemiluminescence immunoassay market over the forecast period. For instance, on June 22, 2020, Abbott Laboratories, located in Mumbai, India, began to distribute its laboratory-based serology blood test for the detection of the antibody IgG (Immunoglobulin G), which determines whether a person has been infected with the novel coronavirus (COVID-19). Abbott has the capacity to supply millions of tests to India and has delivered antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu & Kashmir, and Gujarat. The SARS-CoV-2 IgG test from Abbott can be used for highly reliable, large-scale antibody testing, as recommended by the ICMR (Indian Council of Medical Research) for the use of IgG CLIA (Chemiluminescence immunoassay) tests.

Market players focused on product launches is expected to propel the growth of the global chemiluminescence immunoassay market. For instance, on July 25, 2019, STRATEC SE, a global company that develops and manufactures analyzer systems and automation systems for in-vitro diagnostics, has taken another step toward diversifying its product portfolio by introducing stand-alone modules and a new chemiluminescence immunoassay KleeYa. The KleeYa analyzer is an open platform system that can be used by a variety of providers.

Market players and government authorities are involved in expanding their global presence by adopting strategies such as acquisitions and collaborations, is expected to drive the growth of the global chemiluminescence immunoassay market. For instance, on November 16, 2020, Biomedical Advanced Research and Development Authority (BARDA), U.S. expanded its existing partnership with DiaSorin Inc. in the development of COVID-19 immunoassays. DiaSorin plans to develop and sell its new fully automated chemiluminescence immunoassay in the U.S. and around the world and obtain regulatory approval for semi-quantitative detection of SARS CoV2 virus IgG antibodies in human serum and plasma. The test is designed to help determine the patient's exposure and immune status to the SARSCoV2 virus and COVID-19.

Key features of the study:

  • This report provides an in-depth analysis of global chemiluminescence immunoassay market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global chemiluminescence immunoassay market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global chemiluminescence immunoassay market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global chemiluminescence immunoassay market

Detailed Segmentation:


Global Chemiluminescence Immunoassay Market, By Product Type:

  • Analyzers
  • Automated
  • Semi-automated
  • Reagents
  • Luminophore Markers
  • Enzymatic Markers
  • Consumables

Global Chemiluminescence Immunoassay Market, By Application:

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Others

Global Chemiluminescence Immunoassay Market, By End User:

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Global Chemiluminescence Immunoassay Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa

By Country/Region:

  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • DiaSorin S.p.A.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche AG
  • Inova Diagnostics, Inc.
  • Maccura Biotechnology Co., Ltd.
  • Tosoh Corporation
  • Ortho Clinical Diagnostic
Frequently Asked Questions about the Chemiluminescence Immunoassay Market

What is the estimated value of the Chemiluminescence Immunoassay Market?

The Chemiluminescence Immunoassay Market was estimated to be valued at $6.01 Billion in 2021.

What is the growth rate of the Chemiluminescence Immunoassay Market?

The growth rate of the Chemiluminescence Immunoassay Market is 7.7%, with an estimated value of $10.1 Billion by 2028.

What is the forecasted size of the Chemiluminescence Immunoassay Market?

The Chemiluminescence Immunoassay Market is estimated to be worth $10.1 Billion by 2028.

Who are the key companies in the Chemiluminescence Immunoassay Market?

Key companies in the Chemiluminescence Immunoassay Market include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio, Medical Electronics Co. Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann, La Roche AG and Maccura Biotechnology Co. Ltd..

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Porter’s Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. COVID - 19 Impact Analysis
  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Chemiluminescence Immunoassay
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Chemiluminescence Immunoassay Market, By Product Type, 2017 - 2028 (US$ Billion)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Automated
  • Semi-automated
  • Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Luminophore Markers
  • Enzymatic Markers
  • Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)

6. Global Chemiluminescence Immunoassay Market, By Application, 2017 - 2028 (US$ Billion)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Therapeutic Drug Monitoring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Anastomotic Urethroplasty
  • Substitution Urethroplasty
  • Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Infectious Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Autoimmune Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)

7. Global Chemiluminescence Immunoassay Market, By End User, 2017 - 2028 (US$ Billion)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Clinical Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)

8. Global Chemiluminescence Immunoassay Market, By Region, 2017 - 2028 (US$ Billion)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
  • Regional Trends
  • North America
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Product Type,2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Bn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape
  • Company Profiles
  • DiaSorin S.p.A.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche AG
  • Inova Diagnostics, Inc.
  • Maccura Biotechnology Co., Ltd.
  • Tosoh Corporation
  • Ortho Clinical Diagnostic

Key pointers provided are also applicable to other companies covered in the scope of the report.
  • Analyst Views

10. Section
  • Research Methodology
  • About us
  • Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Siemens Healthineers
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche AG
  • Inova Diagnostics Inc.
  • Maccura Biotechnology Co. Ltd.
  • Tosoh Corporation
  • Ortho Clinical Diagnostic